Sales rise 15.23% to Rs 120.61 crore
Net profit of Tatva Chintan Pharma Chem declined 49.06% to Rs 11.62 crore in the quarter ended December 2022 as against Rs 22.81 crore during the previous quarter ended December 2021. Sales rose 15.23% to Rs 120.61 crore in the quarter ended December 2022 as against Rs 104.67 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales120.61104.67 15 OPM %14.8522.89 -PBDT16.6127.54 -40 PBT14.2225.47 -44 NP11.6222.81 -49Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
